Cargando…

How Symptomatic Should a Hypertrophic Obstructive Cardiomyopathy Patient Be to Consider Alcohol Septal Ablation?

Detalles Bibliográficos
Autores principales:	Jones, Brandon M., Krishnaswamy, Amar, Smedira, Nicholas G., Desai, Milind Y., Tuzcu, E. Murat, Kapadia, Samir R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524122/ https://www.ncbi.nlm.nih.gov/pubmed/28512113 http://dx.doi.org/10.1161/JAHA.117.006292

Ejemplares similares

Association of Septal Myectomy With Quality of Life in Patients With Left Ventricular Outflow Tract Obstruction From Hypertrophic Cardiomyopathy
por: Desai, Milind Y., et al.
Publicado: (2022)

Characteristics and Outcomes of Elderly Patients With Hypertrophic Cardiomyopathy
por: Alashi, Alaa, et al.
Publicado: (2021)

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
por: El Masry, Hicham, et al.
Publicado: (2008)

Alcohol septal ablation in hypertrophic cardiomyopathy
por: Mateo, Juan José Santos, et al.
Publicado: (2018)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
por: Scholtz, Smita, et al.
Publicado: (2023)

Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
por: Rigopoulos, Angelos G., et al.
Publicado: (2016)

Role of endocardial septal ablation in the treatment of hypertrophic obstructive cardiomyopathy
por: Aksu, Tolga, et al.
Publicado: (2016)

Septal Ablation Versus Surgical Myomectomy for Hypertrophic Obstructive Cardiomyopathy
por: Pelliccia, F., et al.
Publicado: (2021)

Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy
por: Arévalos, Victor, et al.
Publicado: (2021)

Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: A comparison with medical therapy
por: Li, Peijin, et al.
Publicado: (2021)

Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
por: Yang, Qiulan, et al.
Publicado: (2021)

Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
por: Achim, Alexandru, et al.
Publicado: (2023)

Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long‐Term Follow‐Up Study Based on the Euro‐Alcohol Septal Ablation Registry
por: Veselka, Josef, et al.
Publicado: (2017)

Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care
por: Faber, Lothar
Publicado: (2014)

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy – 8 years follow up
por: Sathyamurthy, I., et al.
Publicado: (2014)

Age‐related survival after alcohol septal ablation in hypertrophic obstructive cardiomyopathy
por: Batzner, Angelika, et al.
Publicado: (2021)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
por: Gragnano, Felice, et al.
Publicado: (2023)

Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
por: Alabdaljabar, Mohamad S., et al.
Publicado: (2023)

Implantable cardioverter-defibrillator implantation should be considered in high-risk patients with apical hypertrophic cardiomyopathy as the same manner with the septal type
por: Park, Y M, et al.
Publicado: (2023)

Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
por: Zheng, Xifeng, et al.
Publicado: (2022)

Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy
por: Hermida, Uxio, et al.
Publicado: (2022)

Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy
por: Bogachev-Prokophiev, A, et al.
Publicado: (2015)

TTR sequencing should be considered ahead of hypertrophic cardiomyopathy in Afro-Americans
por: Raphalen, Jean Herlé, et al.
Publicado: (2015)

Outcomes in Guideline‐Based Class I Indication Versus Earlier Referral for Surgical Myectomy in Hypertrophic Obstructive Cardiomyopathy
por: Alashi, Alaa, et al.
Publicado: (2020)

Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest for the septal coronary anatomy
por: Steggerda, R. C., et al.
Publicado: (2013)

Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
por: Bytyçi, Ibadete, et al.
Publicado: (2020)

Cerclage Septal Ablation for Hypertrophic Cardiomyopathy: Will a Backdoor Attack on the Septum Be Better?
por: Bach, Richard G.
Publicado: (2020)

Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report
por: Tengiz, Istemihan, et al.
Publicado: (2006)

A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy
por: Shelke, Abhijeet B., et al.
Publicado: (2016)

Outcome of patients ≥ 60 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
por: Jahnlová, Denisa, et al.
Publicado: (2019)

Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
por: Liu, Qiang, et al.
Publicado: (2021)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

Midterm Outcome After Septal Myectomy and Medical Therapy in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy
por: Sun, Jiejun, et al.
Publicado: (2022)

Pulmonary Hypertension in Mitral Regurgitation
por: Patel, Harsh, et al.
Publicado: (2014)

From 100 to 0: Endocardial Radiofrequency Ablation of Septal Hypertrophy for Management of Hypertrophic Cardiomyopathy
por: Peigh, Graham, et al.
Publicado: (2020)

Efficacy and safety of alcohol septal ablation in patients over 65 years old with obstructive hypertrophic cardiomyopathy
por: Cheddadi, Laila, et al.
Publicado: (2017)

Percutaneous Transluminal Septal Myocardial Ablation for Hypertrophic Obstructive Cardiomyopathy Under Extracorporeal Membrane Oxygenation Support
por: Kobayashi, Takahiro, et al.
Publicado: (2020)

Sex-Related Differences among Adults with Hypertrophic Obstructive Cardiomyopathy Undergoing Transcoronary Ablation of Septal Hypertrophy
por: Alyaydin, Emyal, et al.
Publicado: (2023)

Incremental Prognostic Utility of Left Ventricular Global Longitudinal Strain in Hypertrophic Obstructive Cardiomyopathy Patients and Preserved Left Ventricular Ejection Fraction
por: Tower‐Rader, Albree, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jegpnal9gat0hmjm1r4jhrhuep